SUPPLEMENTARY METHODS
Plasmids for protein expression α270-His 6 and α270: The dnaE + plasmid pND517 (60) was used as PCR template (with primers 891 and 1563, below) to produce a fragment encoding α270 with a C-terminal His 6 -tag between NdeI and EcoRI sites. After restriction digestion, the fragment was inserted between the same sites in vector pETMCSI (33) to generate the T7-promoter vector pKO1367. Plasmid pKO1439, containing the gene encoding untagged α270 was made similarly (with primers 891 and 1962). εCTS 59 and the εCTS 59 -His 6 amber mutant: The T7 expression construct for εCTS 59 (containing Met185-Ala243 of ε, preceded by a biotinylation tag; Figure 1B ) was made in two steps. Vector pKO1316 was made by annealing complementary oligonucleotides 907 and 908 and inserting them between the NdeI and MluI sites of pETMCSI, eliminating the original NdeI site and creating a new one after codons for a biotinylation sequence (61) . Next the dnaQ + plasmid pSH1017 (36) was used as template with primers 975 and 988; insertion of the resulting fragment between the NdeI and EcoRI sites of pKO1316 gave pKO1422.
A T7 promoter vector was also made for expression of a version of εCTS 59 with a C-terminal unnatural amino acid (UAA) followed by a His 6 -tag. The constructs encoding εCTS 59 -UAA-His 6 was created by PCR with pKO1422 as template, using primers 514 and 1996. The amplified fragments were digested with NdeI and EcoRI for subsequent insertion between the corresponding sites of pETMCSI to give pεCTS-1996. 
εCTS-α270 fusion proteins (constructs A):
The gene encoding the εCTS 35 -α270 fusion protein (construct A, comprising residues 209-243 of the εCTS fused via a 9 amino acid linker [sequence: TRESGSIGS] to the N-terminus of α270; Figure 1C ) was made by strand-overlap extension PCR following amplification in the first step of a dnaQ fragment from pSH1017 (primers 2224 and 2225) and a dnaE fragment from pKO1367 (primers 1962 and 2223). The two fragments were combined and used as template in the second step (primers 1962 and 2225). The fragment was digested with NdeI and EcoRI and inserted at the same sites in pETMCSI to give pKO1479.
A version of this construct with a C-terminal His 6 -tag (plasmid pKO1497) was made similarly (template pKO1479 and primers 1563 and 2225). Subsequent DNA sequencing revealed that pKO1479 and pKO1497 contained a PCR-generated mutation in dnaE(270), encoding α270(Leu21Pro). Consequently, the wild-type versions of both plasmids, named pKO1479wt and pKO1497wt, were made similarly. A longer version of this construct, εCTS 44 -α270 (comprising residues 200-243 of the εCTS fused to the Nterminus of the Leu21Pro mutant of α270) was made using primers 564 and 566 to amplify the α270 fragment from pKO1479, and primers 565 and 568 to amplify the dnaQ(200-243) fragment from pSH1017. The second PCR step used primers 564A and 568. After cleavage with NdeI and EcoRI, the fragment was inserted between these sites in pETMCSI to give plasmid pNH1543. 
α270-εCTS fusion protein (constructs B)
The fusion construct B (α270-εCTS 35 ) comprises residues 209-243 of εCTS fused to the C-terminus of α270 via the same 9-residue linker as used for constructs A ( Figure 1C ). The α270-encoding portion was PCR-amplified from pND517 using primers 891 and 2308 and the segment encoding residues of the εCTS was amplified from pKO1422 using primers 975 and 2307. The products were gel purified, combined in equimolar ratio and used as template for a second PCR with primers 891 and 975. Digestion with NdeI and EcoRI, gel-purification and insertion into pETMCSI created the expression vector pKO1559. A version of α270-εCTS with an N-terminal His 6 -tag was created by insertion of the ~1 kb NdeI-EcoRI fragment from pKO1599 between the same sites of pETMCSIII (33) Figure  1A ). The similar plasmids pSJ1448 and pSJ1449 that direct expression of ε Q 193 (Gln182Ala mutant; weakened CBM) and ε L 193 (Thr183Ala/Met185Leu/Ala186Pro/Phe186Leu mutant; strengthened CBM), respectively, were constructed by an identical procedure, but using plasmids pSJ1445 and pSJ1446 (25) as templates for PCR. Full-length α, His 6 -α and His 6 -α GL : The dnaE gene was amplified from pND517 using PCR primers 891 and 897. The resulting PCR fragment was digested with NdeI and EcoRI and the ~3570 bp product isolated from an agarose gel. Insertion into the corresponding sites of pETMCSI yielded the plasmid pKO1341, which directs the expression of dnaE under transcriptional control of the T7 promoter. The dnaE + NdeI-EcoRI fragment from pKO1341 was isolated and then inserted between the same sites in pETMCSIII to give plasmid pKO1533, which directs expression of the α subunit with an N-terminal His 6 -tag.
For construction of a similar vector expressing the His 6 -α GL (V832G/A921L/M923L) triple mutant ( Figure  1D ), dnaE + gene fragments of 665, 2005 and 366 bp were amplified using pSJ1392 (25) as template and the primer pairs 2476 and 2483, 2481 and 2482, and 2479 and 2480, respectively. The mutated gene was reassembled from the three gel-isolated fragments by strand overlap extension PCR with primers 2476 and 2479. The resulting 2.4 kb fragment from the second PCR coded for the triple mutant V832G/A921L/M923L. After digestion with XhoI and StuI, the product (2.4 kb) was isolated from a gel and inserted between the same two sites in pKO1533 to give pKO1536. 
Primers used to construct Bpa mutants of α270
In the table below, codons of mutated amino acids are underlined and mutated bases are in bold. a Primers used for circularization of PCR-generated templates for cell free synthesis of Bpa mutants of α270. b Outside primers used for PCR-generated templates for cell free synthesis of Bpa mutants of α270. c Forward and reverse primers to generate the Pro4Bpa mutant of α270. d Forward and reverse primers to generate the Ala25Bpa mutant of α270. e Forward and reverse primers to generate the Asp75Bpa mutant of α270. f Forward and reverse primers to generate the Gln106Bpa mutant of α270. g Forward and reverse primers to generate the Lys229Bpa mutant of α270. h Forward and reverse primers to generate the Tyr234Bpa mutant of α270. i Forward and reverse primers to generate the Arg175Bpa mutant of α270. j Forward and reverse primers to generate the Gln237Bpa mutant of α270.
Purification of εCTS-α270 fusion proteins
The εCTS 35 -α270(Leu21Pro) fusion protein (construct A; Figure 1C ) used for crystallography was purified as follows. E. coli BL21(λDE3)recA (27) containing plasmids pLysS (62) and pKO1479 was grown at 37˚C in LB broth containing 50 mg l -1 thymine, 200 mg l -1 ampicillin and 35 mg l -1 chloramphenicol to A 600 = 0.8-1.0, whereupon IPTG was added to 0.5 mM and growth continued for a further 3 h. A suspension of cells (19.9 g from 6 liters of culture) in 300 ml of lysis buffer [50 mM Tris.HCl (pH 7.6), 2 mM EDTA, 2 mM dithiothreitol, 20 mM spermidine, 0.5 mM phenylmethyl sulfonyl fluoride, 10% (w/v) sucrose] was passed twice through a French Press at 10,000 psi, before being clarified by centrifugation. Proteins in the supernatant were precipitated by addition of ammonium sulfate (0.2 g per ml of lysate) followed by gentle agitation over 45 min at 4˚C, and harvested by centrifugation. The pellet was resuspended in 80 ml of Buffer E [50 mM Tris.HCl (pH 7.6), 1 mM dithiothreitol, 1 mM EDTA, 20% (v/v) glycerol] and dialyzed against Buffer E+160 mM NaCl before being passed through a column (2.5 x 12 cm) of DEAE-Toyopearl 650M that had been equilibrated with the same buffer. The εCTS-α270 protein did not bind to the column and was collected in the flow through fractions; this step removes nucleic acids that otherwise interfere with later steps. Fractions were pooled (120 ml), dialysed against 2 changes of 1 l of Buffer E (without salt), and reloaded onto a similar column equilibrated with Buffer E. Proteins were eluted in a gradient (500 ml) of 0-0.25 M NaCl in Buffer E. The εCTS-α270 protein eluted at ~60 mM NaCl.
Ten 10 ml fractions retained from this step were frozen separately at -80°C for storage. Two of the peak fractions (20 ml) were later thawed, diluted with 30 ml of Buffer E and split into 5 aliquots that were separately applied to a MonoQ 10/100 GL column (GE Healthcare) and eluted in gradients (64 ml) of 30-400 mM NaCl in Buffer E. On each occasion, the highly purified εCTS-α270 eluted at ~130 mM NaCl. The combined yield was ~43 mg. Its molecular mass was confirmed by ESI-MS after dialysis into 0.1% formic acid (observed: 34,454.8 ± 0.2; calculated: 34,438.1, assuming loss of the N-terminal f-Met). The α270-εCTS (construct B) and other εCTS-α270 (construct A) fusion proteins were purified similarly.
Purification of His 6 -α GL
His 6 -α GL was expressed in vivo and purified as follows. BL21(λDE3)recA/pLysS/pKO1536 was grown at 30˚C in 5 liters of Z-medium supplemented with 100 mg l -1 ampicillin and 33 mg l -1 chloramphenicol in a 20-liter fermenter (9) . Overexpression of α GL was induced by addition of 1 mM IPTG at A 595 = 1.4 and the culture was incubated for another 11 h at 24˚C, yielding 54.4 g of cells. The cells were resuspended in 300 ml of lysis buffer (9) and disrupted using a French press at 12,000 psi. The lysate was clarified and proteins in the supernatant (325 mL) were precipitated by addition of ammonium sulfate (97.5 g) at 4˚C. The precipitate was collected by centrifugation and dissolved with 75 mL of buffer A [50 mM HEPES-KOH (pH 7.5), 300 mM NaCl, 20 mM imidazole, 5% (v/v) glycerol]. The solution was divided into two batches for purification on a 5 mL column of Ni-NTA in buffer A with a linear imidazole gradient (20 to 500 mM). The total eluate (100 ml) was dialyzed against buffer B [20 mM Tris-HCl (pH 7.55), 1 mM EDTA, 2 mM dithiothreitol, 5% (v/v) glycerol] and loaded onto a DEAE-Toyopearl 650M column (2.5 x 13 cm); His 6 -α L was eluted in a NaCl gradient (0-1 M in buffer B). Pooled fractions containing His 6 -α L (115 ml) were dialyzed against buffer P [20 mM sodium phosphate (pH 6.6), 4 mM EDTA, 1 mM dithiothreitol, 10% (v/v) glycerol] for fractionation on a freshly activated and packed phosphocellulose column (2.5 x 9 cm) with a linear gradient of 0 to 1 M NaCl in buffer P. The purity of α GL in collected fractions was carefully assessed by SDS-PAGE and only samples with <5% impurities were retained. Less pure fractions were successfully turned into high quality samples by re-chromatography on the phosphocellulose column. More than 60 mg of the mutant α GL was obtained in high purity.
Molecular modeling
Modeling of the structure of the structure of the E. coli (Eco) αεθ:β 2 :DNA complex in the polymerization mode commenced with (i) docking of the X-ray structure of the Eco β 2 :DNA complex (PDB: 3BEP) onto that of the full-length Taq α complex with primer-template DNA (PDB: 3E0D), which brings the internal CBM of α into proximity with one of the protein-binding sites of β 2 , essentially as described by Wing et al. (55); (ii) structural alignment and replacement of corresponding domains in the higher-resolution structure of full-length Taq α (PDB: 2HPI) with those of Eco α917 (PDB: 2HNH) followed by homology modeling of the remaining domains (residues 918-1160) of Eco α (using PDB: 3E0D); and (iii) minor alignment of the NMR structure of θ in the ε186:θ complex (16) based on the position of HOT in the X-ray structure of ε186:HOT (PDB: 2IDO). The domain orientations in model (ii) were then adjusted to overlay optimally with those of model (i) to give a model for the Eco α:β 2 :DNA complex (iv). Next, our 1.7 Å structure of εCTS 35 -α270(L21P) (Figure 2 ) was overlaid on the α PHP domain in model (iv) and used to replace it in all regions of close identity, i.e., ignoring changes around the L21P mutation in α270, to give model (v). The additional region of α-ε contact in εCTS 44 -α270(L21P) was then built into this model (vi). Next, the CBMs in ε (residues 182-187) and α (residues 920-924) were modeled into the two protein-binding sites of β 2 , based on the most closely related structures of β 2 -peptide complexes; PDB: 1JQL (63) and 3Q4L (64), respectively, and the side chain conformations of the β 2 pocket and the CBM in ε were refined using Rosetta FlexPepDock (65) . At this point, it was possible to demonstrate (vii) that a random coil peptide corresponding to the flexible Q-linker of ε (residues 188-201) is able to flexibly bridge the gap between the CBM bound to β 2 and the site of (weak) interaction of residues 202-205 of ε with the region around His183 and Asp252 in the PHP domain of α, and (viii) that the εθ sub-complex is still able, without steric clashes, to fit between its binding sites on β 2 and the PHP domain of α to form a compact structure that orients the active site of ε inwards to be placed near the double-stranded DNA that runs between the central channel of β 2 and the active site of α (e.g., in Figure 6A ).
Files to enable detailed visualization of models are available at the website: http://compbio.anu.edu.au/huber/Pol3. Table S1 . X-ray data collection and refinement statistics (molecular replacement). S210  K211  L212  R213  V214  V215  F216  A217  T218  D219  E220  E221  8.36  122.1  54.3  I222  A223  A224  H225  E226  A227  R228  L229  D230  L231  V232  Q233  K234  K235  G236  G237 8.10 110.0 42.9 S238 C239 L240 W241 R242 A243
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1 At 25˚C in 20 mM Tris.HCl (pH 7.0), 150 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol. The assignments rely on the uniqueness of amino acid pairs in the amino acid sequence of εCTS 59 and on 3D HNCA and HN(CO)CA experiments with combinatorially 13 C-and uniformly 15 N-labeled samples. 2 The table lists the full amino-acid sequence of the εCTS 59 construct. Residue numbers pertain to ε and are omitted for residues preceding the ε segment. Blank lines identify residues for which no peaks could be identified in the 15 N-HSQC spectrum. 3 Three peaks were resolved in the 15 N-HSQC spectra for residues Q195, Q196 and Q197
but their precise sequence-specific assignment could not be established due to insufficient spectral resolution in the 3D NMR experiments. The complex of α270 with ε and θ can be photo-crosslinked for the mutant Lys229Bpa but not for the mutants Pro4Bpa, Asp75Bpa, Gln106Bpa, or the wild-type; 15% SDS-PAGE with Coomassie blue staining. The bands of α270, ε and θ and the crosslinked product of the Lys229Bpa mutant (CL) are indicated on the right. The + and -symbols identify the samples prepared with and without UV irradiation at 312 nm. (C) The Lys229Bpa mutant of α270 can similarly be photo-crosslinked with εCTS 59 instead of the ε:θ complex, indicating that the crosslink is with the εCTS also in full-length ε. The control with wildtype α270 shows that crosslinking depends on incorporation of Bpa; 15% SDS-PAGE with Coomassie blue staining. The bands of α270 and εCTS 59 and the crosslinked product of the Lys229Bpa mutant (CL) are indicated. Purification using the His 6 tag of α270 also copurified the His 6 tagged aminoacyl-tRNA synthetase (BpaRS) used for cell-free production of the Lys229Bpa mutant of α270. The + and -symbols identify the samples prepared with and without UV irradiation at 312 nm. T, total cell free reaction product; S, soluble fraction; P, purified complex. 
